Answers are grounded in this paper and cite their sources.
This study aims to investigate the phenolic compounds and pharmacological potential of Grimmia ovalis (Hedw.) Lindb. to understand their bioactive potential and to pioneer future research. It also aims to be one of the first studies on G. ovalis's in silico bioactivity. HPLC analysis revealed the detection of some phenolic compounds in G. ovalis extract. The study revealed the in silico antimicrobial potential of some phenolic compounds. We calculated that compounds of 2,5-dihydroxybenzoic acid and caffeic acid would inhibit Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (MurB) at micromolar levels. We concluded that they interacted with residues crucial for antimicrobial activity on the mentioned macromolecule.
No takes yet. Share an insight, caveat, or question.
Çambay et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: